Journal of Basic Microbiology
1989
Jochen Gartz
22 citations
Abstract Mycelial cultures of Psilocybe cubensis capable of forming psilocybin and psilocin de novo display a high capacity for hydroxylation of tryptamine derivatives at the 4‐position. A specific biotransformation of added synthetic N,N‐diethyl‐tryptamine was found. Thus high amounts of 4‐hydroxy‐N,N‐diethyltryptamine (up to 3.3%) and a minor quantity of 4‐phosphoryloxy‐N,N‐diethyltryptamine...
International Journal of Crude Drug Research
1989
J. Gartz
27 citations
Analysis of ten fruit bodies of Inocybe aeruginascens Babos revealed a content of the indole derivative aeruginascin which was in the same order of magnitude as the amounts of psilocybin or baeocystin. There was a correlation between the content of psilocybin, baeocystin and aeruginascin. Aeruginascin seems to modify the pharmacological action of psilocybin to give an always euphoric mood...
Zeitschrift für Naturforschung C
August 1, 1988
Rudolf Brenneisen, Stefan Borner
10 citations
The content of tryptamine derivatives in Psilocybe semilanceata, a popular hallucinogenic mushroom, was measured by high-performance liquid chromatography. Most of the 52 samples have been collected at several localities in Switzerland during a 1-5 year period. The content of psilocybin and baeocystin varied in the range of 0.21-2.02% and 0.05-0.77%, respectively, whereas only traces of...
Clinical Pediatrics
February 1, 1988
Richard H. Schwartz, D. E. Smith
51 citations
Ingestion of mushrooms containing psilocybin produces hallucinogenic effects and has become a popular form of substance abuse among some adolescents and young adults. We have reviewed the medical literature on psilocybin mushrooms and describe current patterns of use, provide background material on the botony and pharmacology of these crude drugs, and report results of a small study on usage...
Planta Medica
December 1, 1987
J. Gartz
20 citations
INOCYBE AERUGINASCENS contains psilocybin, baeocystin, and aeruginascin with a still unknown structure in the caps and the stipes. The content of psilocybin and baeocystin has been investigated. The psilocybin and baeocystin content of mushrooms from the same location and with similar mass varied. No correlation has been found between the mass of the mushrooms and the content of psilocybin and...
Chemical and Pharmaceutical Bulletin
1986
Genjiro Kusano, Yutaka Koike, Hideo Inoue et al.
21 citations
Cerevisterol (1) and a new acetylenic compound, 4, 6-decadiyne-1, 3, 8-triol (2) were isolated and characterized from a hallucinogenic mushroom, Gymnopilus spectabilis (FR.) A. H. SMITH, along with ergosterol, ergosteryl peroxide and choline.Psychoactive compounds such as psilocybin and related compounds have not been detected in our collections of this mushroom, though some psilocybin has been...
The Tohoku Journal of Experimental Medicine
1986
Morihiro Musha, Atsushi Ishii, Fumio Tanaka et al.
15 citations
Five cases of poisoning by indigenous mushroom Hikageshibiretake (Psilocybe argentipes) are reported. As this mushroom contains psilocybin, in general, clinical features were similar to those seen by pure psilocybin. Acute toxic stuporous state with complete amnesia in the culminating period occurred in one case, psychedelic state with dreamy consciousness in one case and psychotic adverse...
Journal of Drug Education
June 1, 1985
John Paul Thompson, M. Douglas Anglin, William A. Emboden et al.
16 citations
This study investigated the extent of hallucinogenic mushroom use among 1507 college students and compared mushroom users to nonusers. The subjects, who completed an anonymous questionnaire, were students from California State University, Northridge, and the University of California, Los Angeles. The major finding was that among the respondents who reported use of hallucinogenic drugs (17%),...
Psychiatric Clinics of North America
December 1, 1984
S Cohen
The hallucinogenic drugs represent a recurrent outbreak pattern with each generation or two seeming to rediscover their ego-dissolving effects. The inhalants produce a short-lived intoxication with certain volatile solvents affecting specific organ systems.
Pharmacology, Biochemistry, and Behavior
May 1, 1981
Randall L. Commissaris, William H. Lyness, Richard H. Rech
29 citations
The purpose of the present study was to determine the role of central 5-hydroxytryptamine (5-HT) neuronal systems in the effects of d-lysergic acid diethylamide (LSD), 2,5-methoxy-4-methylamphetamine (DOM), pentobarbital (PB) and methaqualone (MQ) on punished responding in rats. Water-deprived rats were trained to drink from a tube that was electrified at intervals (variable interval 21 sec;...